Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
7.92
-0.23 (-2.82%)
At close: Jun 16, 2026, 4:00 PM EDT
7.85
-0.07 (-0.88%)
After-hours: Jun 16, 2026, 7:23 PM EDT
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $479.4 million as of June 16, 2026. Its market cap has increased by 318.58% in one year.
Market Cap
479.40M
Enterprise Value
276.71M
1-Year Change
318.58%
Ranking
Category
Stock Price
$7.92
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $479.40M, a decrease of -46.62%. That is a compound annual growth rate of -23.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 479.40M | -10.73% |
| Dec 31, 2025 | 537.02M | 232.60% |
| Dec 31, 2024 | 161.46M | -82.02% |
| Feb 8, 2024 | 898.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Valneva SE | 501.51M |
| AgomAb Therapeutics NV | 493.46M |
| Eikon Therapeutics | 491.04M |
| Arvinas | 478.75M |
| Rezolute | 477.41M |
| Sutro Biopharma | 466.79M |
| Neurogene | 463.79M |
| Contineum Therapeutics | 463.22M |